Clinical trials: Bronchiectasis With Acute Exacerbation
Bronchiectasis With Acute Exacerbation
Prevention of OM-85 on Bronchiectasis Exacerbation
Non-cystic fibrosis bronchiectasis is characterized by irreversible dilatation of the medium-sized bronchi as a result of airway injury due to recurrent or chronic inflammation and infection.
- Trial name
- NCT01968421
- Testing
- OM-85 BV
- Where
- 2 sites in China
- Volunteers
- 196 people
- Sponsor
- Chinese Academy of Medical Sciences
Non-Cystic Fibrosis Bronchiectasis
Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis
This is a multi-centered, randomized, controlled study to assess the efficacy, indications and adverse reactions of combined administration of nebulized amikacin in patients with acute exacerbation of non-cystic fibrosis…
- Trial name
- NCT02081963
- Testing
- Amikacin, Normal saline
- Where
- China
- Volunteers
- 178 people
- Sponsor
- Qilu Hospital of Shandong University